AI-generated summary
The authors randomized 80 people with head and neck cancer receiving radiotherapy to red light (660 nm), near-infrared light (810 nm), or both, for 42 days to assess oral mucositis. The combined-wavelength group had lower oral mucositis scores than the other two groups, while pain scores did not differ between groups.
- Participants
- 80
- Who or what was studied
- Adults with head and neck cancer undergoing radiotherapy, with or without chemotherapy
- Wavelengths
- 660, 810 nm
- Limits stated in the abstract
- The abstract does not describe the size of each group or the certainty of the evidence, and it reports only group-level score differences.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 810 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Oral mucositis, Laser, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.